| Trial ID: | L3102 |
| Source ID: | NCT00362765
|
| Associated Drug: |
Fenofibrate
|
| Title: |
Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Dyslipidemia
|
| Interventions: |
DRUG: Fenofibrate|DRUG: Metformin|DRUG: Placebo
|
| Outcome Measures: |
Primary: Endogenous Glucose Production (EGP) and Glucose Disposal Rate (GDR) by two-step hyperinsulinemic euglycemic clamp (HEC), 16 weeks | Secondary: Gluconeogenesis, Glycogenolysis, Skeletal muscle and liver fat content, Abdominal fat content, Body energy expenditure and respiratory quotient, Lipids and glycemic parameters, 16 weeks
|
| Sponsor/Collaborators: |
Sponsor: Solvay Pharmaceuticals
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
8
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2006-10
|
| Completion Date: |
2007-07
|
| Results First Posted: |
|
| Last Update Posted: |
2008-08-13
|
| Locations: |
Site 2, Turku, Finland|Site 3, Dublin, Ireland|Site 1, Pisa, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT00362765
|
